A prominent Senate panel on Wednesday unanimously passed a new package of health policy reforms that would rein in certain PBM practices and ensure Medicare patients aren't paying more than insurers do for medications.
Sage Therapeutics has priced the oral postpartum depression pill it developed with partner Biogen at $15,900 for a full 14-day course of treatment, the company said on Tuesday.
The two companies have been the primary beneficiaries of the global boom in obesity drugs, ballooning their market values and reshaping expectations not just in the healthcare industry, but also for sellers of sugary snacks, nutritional aids and packaged foods.